Verastem (VSTM) Stock Price Target Lowered to $18 by BTIG
Published on 5/8/2026
AI Summary
Summarized by AI from the source belowBTIG has lowered the stock price target for Verastem (VSTM) to $18 due to a revenue miss. This adjustment reflects concerns regarding the company's financial performance and future projections. Changes in price targets can impact investor sentiment and market trading behavior. Verastem's response to this target change will be closely monitored by market stakeholders.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
Related News
Earnings
Cardinal Health Raises Price Target After Positive Profit Guidance
Aug 11
Earnings
Hnit-Baltic Uab Announcement: Financial Performance Updates
Aug 11
Earnings
Travere Therapeutics (TVTX) Expands Focus on Rare Disease Treatments
Aug 11
Earnings
Amazon (AMZN) Shares: Jeff Bezos Sells Over $4 Billion Worth
Aug 11